STE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. STE’s longer-term trend remains bullish (stacked moving averages), but near-term momentum is weakening (MACD histogram negative and expanding) while options flow is defensive (put-heavy volume) and insider selling has surged. For an impatient buyer looking to enter immediately, the risk/reward is not attractive at the current ~262.6 level—better to hold off rather than buy into fading momentum ahead of the 2026-02-04 earnings event.
Trend/structure is still constructive: SMA_5 > SMA_20 > SMA_200 signals an established uptrend. However, momentum is deteriorating: MACD histogram at -0.144 is below zero and negatively expanding, implying the recent push higher is losing steam. RSI_6 ~52.6 is neutral, offering no oversold ‘snap-back’ advantage for an immediate entry. Key levels: Pivot ~262.34 is essentially where price is trading; support sits at S1 ~257.09 then S2 ~253.85 (a break below would likely accelerate selling). Resistance is R1 ~267.60 then R2 ~270.84 (needs a momentum turn to clear). Net: bullish trend, but short-term setup is not a clean buy today.
Strong recent operating performance (2026/Q2): revenue +9.89% YoY, net income +27.90% YoY, EPS +29.14% YoY; gross margin improved to 44.23 (+1.56% YoY).
Longer-term technical uptrend intact (bullish moving-average stack).
Pattern-based projection supplied suggests upside bias over the next week/month (model indicates higher probability of gains, though it’s not a timing signal).
Upcoming earnings (2026-02-04 after hours) could act as a catalyst if results/guide exceed expectations.
Insider activity is a clear negative: insiders are selling, with selling amount up 17029.80% over the last month.
Momentum warning: MACD histogram negative and expanding points to weakening price thrust and elevated risk of a pullback toward 257/254 support.
Options tape is put-heavy (volume put/call 2.33), indicating defensive sentiment into the near term.
No supportive news flow in the past week; absent a catalyst, price can drift or mean-revert.
Earnings event risk on 2026-02-04 (any miss or cautious guidance could reprice the stock quickly).
Latest quarter: 2026/Q2. Growth was strong and improving: Revenue rose to 1,460,300,000 (+9.89% YoY), Net Income to 191,900,000 (+27.90% YoY), EPS to 1.95 (+29.14% YoY). Profitability also improved with Gross Margin at 44.23 (up 1.56% YoY). Overall, fundamentals look healthy with accelerating bottom-line growth versus top-line growth.
The provided analyst notes appear inconsistent with the company (they reference Stora Enso rather than STERIS/STE), so they may not be reliable for STE specifically. Based strictly on the supplied text, sentiment is neutral: ratings are Neutral/Equal Weight with modest price-target increases. Interpreting that at face value, Wall Street’s implied view is ‘steady, not a high-conviction upside call.’ Pros: targets nudged higher (incremental optimism). Cons: ratings remain neutral (no strong conviction to chase at current levels).
